| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.27 | 3e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |